Very excited to share the updated diagnostic criteria for #paraneoplastic neurologic syndromes. A collaborative effort from 19 experts from 8 coutries to enhance the clinical care of patients and to encourage standardization of #PNS research initiatives. nn.neurology.org/content/8/4/e1…

After a long gestation, it is out! Here is our latest study on the use of FcRn blockade as a therapeutic strategy in maternal autoantibody-related diseases in the offspring. Thanks to Angela Vincent, Tony Shock, UCB News and the The Vernon Lab! nn.neurology.org/content/8/4/e1…

An excellent lab and exciting project

Interesting results from a functional assay of complement activation by acetylcholine receptor antibodies in myasthenia gravis

💉 Today marks exactly 100 years since Leonard Thompson, a 14-year-old boy dying from type 1 diabetes, became the first person to receive an injection of insulin on 11 January 1922. A thread 👇 (1/6)

Paper out today Science Magazine! We used transcriptome imaging to profile 4000 genes in human cortex and revealed substantial increase in glia-neuron interactions in human over mouse, suggesting the evolution of glia cells may follow a more complexed spatial pattern!

The three deceits of bureaucracy and why we need to oppose them in Brain academic.oup.com/brain/article/…

Very excited to share our new study on anti-DNER ataxia French Reference Center for PNS and AE: ✔️1/3 of patients have a favorable outcome ✔️DNER antibodies bind to the surface of Purkinje cells and are therefore potentially pathogenic, supporting the use of anti-CD20 therapies nn.neurology.org/content/9/5/e2…

Interesting outcome data in an adult onset MOGAD cohort

Informative detailed inmunopathological study of brain tissue in GAD65Ab associated TLE

Nice work @SimonRinaldi78 nn.neurology.org/content/10/1/e…

Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease: bit.ly/3UmLuRZ #NeuroTwitter #NMOSD #MOGAD

New lesions between clinical attacks much less common in MOGAD and AQP4 vs MS

Using in vivo PET imaging in patients recovering from N-methyl-d-aspartate receptors (NMDAR)-antibody encephalitis, this study found a mean 30% reduction in NMDAR density involving widespread cortical areas of the brain. ja.ma/3FrO7xT

Any part time PIs out there willing to share experience?

Cool study from Sk Wright and colleagues

The 2025 ABN Clinical Research Training Fellowships are open for applications! 🩺🧠 We encourage the brightest UK neurology trainees in undertaking world-leading clinical neuroscience research 🌟 Interested? Know someone? Info here: theabn.org/page/Fellowshi…

Big News! We are recruiting for a new Consultant Neurologist to join our Epilepsy team here at the RVI, Newcastle Neurosciences @ NuTH Amazing team, great region - take a look beta.jobs.nhs.uk/candidate/joba… ILAE BRITISH BRANCH Neurology Trainees Association of British Neurologists

This is important: without urgent action clinical academia in the UK is at serious risk of dying out. ukri.org/news/report-ca…

A groundbreaking trial, led from Cambridge University including CUH colleagues, has revealed that immunosuppressing medicines show promise for the treatment of Parkinson’s disease at AD/PD - Advances in Science & Therapy Read more: orlo.uk/FDuaX #ADPD2025